Aclarion, Inc.

ACON Healthcare Health Information Services

Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024. In the quarter to June 2026, revenue grew 30.6%, EPS grew 59.3% and free cash flow fell 41.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.85 0.10 −5.13%
Market cap
$5.6M
P/E
0.0×
Fwd P/E
−0.8×
Dividend yield
—
F-score
5/9
Altman Z
−4.92
Beneish M
−7.47
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
84.72 89.52 32.33 64.81
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(2.67) (2.64) (1.50) (3.76)
P/B ratio
0.42 0.35 0.19 0.35
EV/Sales
(107.19) (151.91) (123.47) (100.17)
EV/EBITDA
0.95 1.42 1.37 1.01
EV/FCF
1.09 1.58 1.27 1.01
Current Ratio
16.20 19.65 14.81 17.01
Net Debt/EBITDA
5.75 6.50 6.23 6.41
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(256.94%) (276.15%) (369.78%) (10,293.66%)
Free Cash Flow Yield
(116.50%) (107.33%) (301.29%) (152.99%)
Free Cash Flow per Share
(1.10) (1.26) (3.14) (2.06)
Book value per Share
6.91 9.23 24.13 21.46
Free Cash Flow
(2.70) (2.69) (1.67) (1.20)
EV/EBIT
0.92 1.38 1.33 0.98
Other line items

Show all line items

Columns are period end dates